关注
David Lukac
David Lukac
Institute of Molecular and Translational Medicine, Palacký University Olomouc
在 upol.cz 的电子邮件经过验证
标题
引用次数
引用次数
年份
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
T Buchtova, D Lukac, Z Skrott, K Chroma, J Bartek, M Mistrik
International Journal of Molecular Sciences 24 (3), 2885, 2023
212023
Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET
T Buchtova, Z Skrott, K Chroma, J Rehulka, P Dzubak, M Hajduch, ...
Molecular Oncology 16 (7), 1541-1554, 2022
82022
Emetine blocks DNA replication via proteosynthesis inhibition not by targeting Okazaki fragments
D Lukac, Z Machacova, P Moudry
Life Science Alliance 5 (12), 2022
62022
DNA polymerase α-primase facilitates PARP inhibitor-induced fork acceleration and protects BRCA1-deficient cells against ssDNA gaps
Z Machacova, K Chroma, D Lukac, I Protivankova, P Moudry
Nature Communications 15 (1), 7375, 2024
2024
系统目前无法执行此操作，请稍后再试。
文章 1–4